{rfName}
Es

Indexed in

License and use

Citations

16

Altmetrics

Analysis of institutional authors

Sans-Pola, CarlaAuthor

Share

October 15, 2024
Publications
>
Article
No

Establishing and Evaluating a Study Questionnaire on Knowledge and Attitudes of Healthcare Professionals Towards Recreational and Medical Cannabis Across Europe

Publicated to:Clinical Drug Investigation. 41 (8): 701-710 - 2021-07-07 41(8), DOI: 10.1007/s40261-021-01058-x

Authors: Jouanjus, Emilie; Sans-Pola, Carla; Mainoli, Beatrice; Javid, Farideh A; Ekheden, Isabella

Affiliations

Inst Recerca Vall dHebron, Immunomediated Dis & Innovat Therapies Res Grp, Barcelona, Spain - Author
Karolinska Univ Hosp, Clin Pharmacol, Stockholm, Sweden - Author
Toulouse Univ Hosp, Addictovigilance Ctr, Dept Med Pharmacol, Toulouse, France - Author
Univ Autonoma Barcelona, Dept Pharmacol Therapeut & Toxicol, Barcelona, Spain - Author
Univ Huddersfield, Sch Appl Sci, Dept Pharm, Huddersfield, W Yorkshire, England - Author
Univ Lisbon, Fac Med, Lab Clin Pharmacol & Therapeut, Lisbon, Portugal - Author
Univ Toulouse III Paul Sabatier, Univ Toulouse, Ctr Epidemiol & Res POPulat Hlth CERPOP, Team EQUITY,UMR Inserm,Fac Med, 37 Allees Jules Guesde, F-31000 Toulouse, France - Author
Vall dHebron Univ Hosp, Clin Pharmacol Serv, Barcelona, Spain - Author
See more

Abstract

Background and Objective The present survey was a preliminary to a European research project on the attitude and knowledge of healthcare professionals towards the use of medical cannabis. The objective was to evaluate the readability, understandability, and relevance of a first version of the study questionnaire before preparing the finalized questionnaire, which will be subsequently proposed to European healthcare professionals on a large scale. Methods A cross-sectional study was conducted between December 2019 and May 2020. We established an electronic evaluation questionnaire relating to the study questionnaire. This evaluation questionnaire was proposed to multidisciplinary experts from all over Europe. Feedback from the evaluation questionnaire was considered for improving and finalizing the study questionnaire. Results 66 evaluation questionnaires were collected from nine European countries (Cyprus, France, Germany, Italy, Lithuania, Portugal, Spain, Sweden, United Kingdom), which corresponded to a participation rate of 41.5%. Most participants were women (65.2%, n = 43). The mean age was 39.5 years +/- 11.6. Each participant could specify several occupations. There were 25 pharmacologists, 24 physicians, ten pharmacists, four university teachers, three epidemiologists or public health experts, one nurse, one biotechnologist, one microbiologist, and one police researcher. Overall, 84.8% of participants were interested in the topic of the survey on the knowledge and attitudes of healthcare professionals towards recreational and medical cannabis across Europe. Participants were satisfied with all but six of the proposed questions. In addition, two additional questions were subject for comments despite a high level of satisfaction. Consequently, the concerned questions (n = 8) were modified. Conclusion This evaluation survey was a necessary step to improve the quality of the future research project. The positive feedback encourages the authors to proceed with the project on a European scale, scheduled for 2021.

Keywords

AdultAttitudeCross-sectional studiesDelivery of health careEuropeFemaleHealth knowledge, attitudes, practiceHumansMarijuanaMedical marijuanaSurveys and questionnaires

Quality index

Bibliometric impact. Analysis of the contribution and dissemination channel

The work has been published in the journal Clinical Drug Investigation due to its progression and the good impact it has achieved in recent years, according to the agency Scopus (SJR), it has become a reference in its field. In the year of publication of the work, 2021, it was in position , thus managing to position itself as a Q2 (Segundo Cuartil), in the category Medicine (Miscellaneous). Notably, the journal is positioned en el Cuartil Q3 for the agency WoS (JCR) in the category Pharmacology & Pharmacy.

From a relative perspective, and based on the normalized impact indicator calculated from the Field Citation Ratio (FCR) of the Dimensions source, it yields a value of: 2.59, which indicates that, compared to works in the same discipline and in the same year of publication, it ranks as a work cited above average. (source consulted: Dimensions Jul 2025)

Specifically, and according to different indexing agencies, this work has accumulated citations as of 2025-07-16, the following number of citations:

  • WoS: 7
  • Europe PMC: 4

Impact and social visibility

From the perspective of influence or social adoption, and based on metrics associated with mentions and interactions provided by agencies specializing in calculating the so-called "Alternative or Social Metrics," we can highlight as of 2025-07-16:

  • The use, from an academic perspective evidenced by the Altmetric agency indicator referring to aggregations made by the personal bibliographic manager Mendeley, gives us a total of: 30.
  • The use of this contribution in bookmarks, code forks, additions to favorite lists for recurrent reading, as well as general views, indicates that someone is using the publication as a basis for their current work. This may be a notable indicator of future more formal and academic citations. This claim is supported by the result of the "Capture" indicator, which yields a total of: 35 (PlumX).

With a more dissemination-oriented intent and targeting more general audiences, we can observe other more global scores such as:

  • The Total Score from Altmetric: 3.95.
  • The number of mentions on the social network X (formerly Twitter): 6 (Altmetric).

Leadership analysis of institutional authors

This work has been carried out with international collaboration, specifically with researchers from: France; Portugal; Sweden; United Kingdom.